← SynDRA
GSK-269962A
SynDRA canonical compound SYN0006456 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ROCK1 | ROCK2 |
|---|
| Mechanism of action | rho associated kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ROCK1 INHIBITOR
- ROCK2 INHIBITOR
- rho associated kinase inhibitor
Cross-references
Synonyms
- GSK269962A
- GSK269962
- GSK-269962
- aminofurazanyl-azabenzimidazole 6n
- GSK 269962
- GSK269962B
- F89KMM7TE2
- RefChem:922534
- Aminofurazanyl-azabenzimidazole 6n
- MFCD09970310
- Kinome_3843
- C29H30N8O5
- UNII-F89KMM7TE2
- MLS006010261
- ROCK inhibitor GS269962A
- GTPL8037
- orb1304125
- SCHEMBL1838346
- ROCK inhibitor GSK269962A
- SCHEMBL29365470
- SCHEMBL29387396
- BDBM14047
- EX-A674
- YOVNFNXUCOWYSG-UHFFFAOYSA-N
- GLXC-90467
- IVA18608
- NSC756162
- AKOS024457925
- NSC-756162
- SDCCGGSK-0000025.P001
- NCGC00241982-01
- NCGC00241982-02
- NCGC00241982-03
- NCGC00241982-04
- NCGC00241982-09
- AC-35298
- AC-35503
- AS-56202
Look up GSK-269962A in the interactive SynDRA portal →